Characterization of raloxifene as potential pharmacological agent against SARS-CoV-2 and its variants
Daniela Iaconis(Telethon Institute Of Genetics And Medicine), Andrea R. Beccari(Dompé (Italy))
Cited by 1
Related Papers
Design of Noncompetitive Interleukin-8 Inhibitors Acting on CXCR1 and CXCR2
|Journal of Medicinal Chemistry|2007|97
Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief
|Proceedings of the National Academy of Sciences|2014|78
The centrosomal OFD1 protein interacts with the translation machinery and regulates the synthesis of specific targets
|Scientific Reports|2017|51
Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls
|Trends in Pharmacological Sciences|2008|28